Researchers used existing technologies to show that exposing the coronavirus to riboflavin and ultraviolet light reduces blood-borne pathogens in human plasma and whole-blood products.
Researchers used existing technologies to show that exposing the coronavirus to riboflavin and ultraviolet light reduces blood-borne pathogens in human plasma and whole-blood products.